Integra LifeSciences Holdings Corp Stock
Integra LifeSciences Holdings Corp dominated the market today, gaining €0.80 (3.030%).
With 3 Buy predictions and 3 Sell predictions the community is currently undecided on Integra LifeSciences Holdings Corp.
With a target price of 45 € there is a hugely positive potential of 65.44% for Integra LifeSciences Holdings Corp compared to the current price of 27.2 €.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | 3.030% | -0.730% | -15.000% | -45.382% | -30.964% | -55.772% | -41.075% |
| Neogen Corp. | 0.910% | 1.835% | -21.277% | -27.922% | -39.344% | -71.899% | -58.636% |
| Bio-Rad Labs Inc. A | -0.890% | -5.249% | -21.130% | -38.245% | -13.931% | -51.867% | - |
| Merit Medical Systems | 0.720% | 0.725% | -0.714% | -5.442% | 2.206% | 34.951% | 41.433% |
Comments
Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $49.00 price target on the stock, up previously from $40.00.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) is now covered by analysts at CL King. They set a "buy" rating and a $50.00 price target on the stock.
Show more
Ratings data for IART provided by MarketBeat